177 related articles for article (PubMed ID: 29983199)
21. Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.
Fu HW
World J Gastroenterol; 2014 May; 20(18):5294-301. PubMed ID: 24833859
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
23. Berberine demonstrates anti-inflammatory properties in Helicobacter pylori-infected mice with chronic gastritis by attenuating the Th17 response triggered by the B cell-activating factor.
Wu X; Li X; Dang Z; Jia Y
J Cell Biochem; 2018 Jul; 119(7):5373-5381. PubMed ID: 29345340
[TBL] [Abstract][Full Text] [Related]
24. The Role of
Fu HW; Lai YC
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613542
[No Abstract] [Full Text] [Related]
25. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection and gastric autoimmune diseases: is there a link?
Presotto F; Sabini B; Cecchetto A; Plebani M; De Lazzari F; Pedini B; Betterle C
Helicobacter; 2003 Dec; 8(6):578-84. PubMed ID: 14632671
[TBL] [Abstract][Full Text] [Related]
27. Th1 immune response to H. pylori infection varies according to the age of the patients and influences the gastric inflammatory patterns.
Freire de Melo F; Rocha GA; Rocha AM; Teixeira KN; Pedroso SH; Pereira Junior JB; Fonseca de Castro LP; Cabral MM; Carvalho SD; Bittencourt PF; de Oliveira CA; Queiroz DM
Int J Med Microbiol; 2014 May; 304(3-4):300-6. PubMed ID: 24373859
[TBL] [Abstract][Full Text] [Related]
28. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques.
Mattapallil JJ; Dandekar S; Canfield DR; Solnick JV
Gastroenterology; 2000 Feb; 118(2):307-15. PubMed ID: 10648459
[TBL] [Abstract][Full Text] [Related]
29. [Immune response to an H. pylori infection in the stomach].
Wakatsuki Y
Nihon Rinsho; 1999 Jan; 57(1):23-31. PubMed ID: 10036932
[TBL] [Abstract][Full Text] [Related]
30. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
31.
Park AM; Omura S; Fujita M; Sato F; Tsunoda I
Clin Exp Neuroimmunol; 2017 Aug; 8(3):215-232. PubMed ID: 29158778
[TBL] [Abstract][Full Text] [Related]
32. Arginase 2 deletion leads to enhanced M1 macrophage activation and upregulated polyamine metabolism in response to Helicobacter pylori infection.
Hardbower DM; Asim M; Murray-Stewart T; Casero RA; Verriere T; Lewis ND; Chaturvedi R; Piazuelo MB; Wilson KT
Amino Acids; 2016 Oct; 48(10):2375-88. PubMed ID: 27074721
[TBL] [Abstract][Full Text] [Related]
33. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.
D'Elios MM; Amedei A; Cappon A; Del Prete G; de Bernard M
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):157-64. PubMed ID: 17521355
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Pedrini MJ; Seewann A; Bennett KA; Wood AJ; James I; Burton J; Marshall BJ; Carroll WM; Kermode AG
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):603-7. PubMed ID: 25602009
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion.
Bodger K; Bromelow K; Wyatt JI; Heatley RV
J Clin Pathol; 2001 Apr; 54(4):285-92. PubMed ID: 11304845
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
37. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18.
Engler DB; Leonardi I; Hartung ML; Kyburz A; Spath S; Becher B; Rogler G; Müller A
Inflamm Bowel Dis; 2015 Apr; 21(4):854-61. PubMed ID: 25742401
[TBL] [Abstract][Full Text] [Related]
39. Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Banati M; Csecsei P; Koszegi E; Nielsen HH; Suto G; Bors L; Trauninger A; Csepany T; Rozsa C; Jakab G; Molnar T; Berthele A; Kalluri SR; Berki T; Illes Z
Eur J Neurol; 2013 Nov; 20(11):1492-5. PubMed ID: 23293933
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori infection and host cell responses.
Di Leo A; Messa C; Russo F; Linsalata M; Amati L; Caradonna L; Pece S; Pellegrino NM; Caccavo D; Antonaci S; Jirillo E
Immunopharmacol Immunotoxicol; 1999 Nov; 21(4):803-46. PubMed ID: 10584213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
